2010
DOI: 10.1590/s1413-86702010000100005
|View full text |Cite
|
Sign up to set email alerts
|

Prevalence of human papillomavirus (HPV) and HPV-16 genotyping by real-time PCR in patients with several cervical pathologies

Abstract: Prevalence of human papillomavirus (HPV) and HPV-16 genotyping by real-time PCR in patients with several cervical pathologies ABSTRACT Purpose: this study was planned to evaluate the prevalence of HPV (excepting type 16) and HPV 16 by real-time PCR in colposcopy patients and to interprete the results with age, age of first sexual intercourse (FSI), parity and Pap smear results. Methods: one hundred and two colposcopy patients (50 and 52 of the patients were classified as colposcopy positive and negative, respe… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2018
2018

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 28 publications
0
1
0
Order By: Relevance
“…Polymerase chain reaction (PCR) based methods amplifying nucleic acids of HPV are commonly used because of the limited sensitivity of Pap smear test leading to sample preparation and interpretation problems, insufficient serological tests and impossibility of in vitro cultures. Detection of HPV DNA, especially in latent infections, can be helpful in detecting cancer and precursor lesions [4]. Real-time PCR techniques have been developed to quantify HPV DNA in clinical samples.…”
Section: Introductionmentioning
confidence: 99%
“…Polymerase chain reaction (PCR) based methods amplifying nucleic acids of HPV are commonly used because of the limited sensitivity of Pap smear test leading to sample preparation and interpretation problems, insufficient serological tests and impossibility of in vitro cultures. Detection of HPV DNA, especially in latent infections, can be helpful in detecting cancer and precursor lesions [4]. Real-time PCR techniques have been developed to quantify HPV DNA in clinical samples.…”
Section: Introductionmentioning
confidence: 99%